Bristol Myers Squibb (NYSE:BMY) posted third-quarter results that beat analysts’ consensus forecast while raising its outlook for the remainder of the year. The New York City-headquartered company announced third-quarter revenues of $10.5 billion and profits of $1.63 per share for the quarter that ended Sept. 30, 2020 . Compared with the same quarter last year, profits…